Prospective study of the feasibility of point-of-care testing strategy for carbapenem-resistant organism detection
Background/aims In an investigator-initiated, prospective study, we evaluated the feasibility of a five-gene sequence point-of-care (POC) testing strategy (Xpert CARBA-R Assay, Cepheid Inc., Sunnyvale, CA, USA), compared to reference laboratory PCR (48 – 72 hours turnaround time, two gene sequences)...
| Váldodahkkit: | , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Georg Thieme Verlag KG
2018-01-01
|
| Ráidu: | Endoscopy International Open |
| Liŋkkat: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0043-122141 |